{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:08:47Z","timestamp":1790050127997,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.pnpbp.2007.07.026","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T11:38:50Z","timestamp":1186659530000},"page":"150-154","source":"Crossref","is-referenced-by-count":41,"title":["Yi-gan san for the treatment of borderline personality disorder: An open-label study"],"prefix":"10.1016","volume":"32","author":[{"given":"Tsuyshi","family":"Miyaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohide","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Hayashia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.07.026_bib1","author":"American Psychiatric Association"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1440-1819.2002.01006.x","article-title":"Effects of yoku-kan-san-ka-chipi-hange on the sleep of normal healthy adult subjects","volume":"56","author":"Aizawa","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib4","article-title":"Pharmacological interventions for people with borderline personality disorder","volume":"25","author":"Binks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The Aggression Questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/ajp.150.12.1843","article-title":"Communication pharmacotherapy of borderline personality with haloperidol and phenelzine","volume":"150","author":"Cornelius","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib8","series-title":"Structured Clinical Interview for DSM-IV axis II Personality disorders (SCID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib9","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"1995"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.npp.1300424","article-title":"Dopamine dysfunction in borderline personality disorder: a hypothesis","volume":"29","author":"Friedel","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2005-837767","article-title":"Emerging evidence for the use of atypical antipsychotics in borderline personality disorder","volume":"38","author":"Grootens","year":"2005","journal-title":"Pharmocopsychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib12","unstructured":"Guy, W. ECDEU Assessment Manual for Psychopharmacogy-Revised, Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976;218\u2013222."},{"key":"10.1016\/j.pnpbp.2007.07.026_bib13","first-page":"429","article-title":"A rating scale for depression","volume":"133","author":"Hamilton","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1601-5215.2002.140203.x","article-title":"Serotonin, personality and borderline personality","volume":"14","author":"Hansenne","year":"2002","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2007.07.026_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.106.022707","article-title":"Omega-3 fatty acid supplementation in patients with recurrent self-harm","volume":"190","author":"Hallahan","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajp.162.3.621","article-title":"Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4088\/JCP.v66n0214","article-title":"A randomized observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients","volume":"66","author":"Iwasaki","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib18","first-page":"151","article-title":"Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs","volume":"19","author":"Liao","year":"1995","journal-title":"Proc Natl Sci Counc Repub China Part B"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1176\/ajp.151.12.1771","article-title":"Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients","volume":"151","author":"Linehan","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-1913-8","article-title":"Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression","volume":"176","author":"New","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1192\/bjp.168.6.723","article-title":"Severe personality disorders. Treatment issues and selection for in-patient psychotherapy","volume":"168","author":"Norton","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00131746-200405000-00003","article-title":"Testing APA practice guideline: symptom-targeted medication utilization for patients with BPD","volume":"10","author":"Oldham","year":"2004","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib23","first-page":"50","article-title":"The Brief Psychiatric Rating Scale","volume":"32","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib24","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1176\/appi.ajp.159.12.2048","article-title":"SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder","volume":"159","author":"Rinne","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1211\/0022357991772853","article-title":"Evaluation of the protective effects of alkaloids isolated from the hooks and stems of uncaria sinesis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats","volume":"51","author":"Shimada","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1993.01820170055007","article-title":"Efficacy of phenelzine and haloperidol in borderline personality disorder","volume":"50","author":"Soloff","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib27","first-page":"105","article-title":"Two cases with positive symptoms by dementia of elderly successfully treated with yokukan-san (in Japanese, abstract in English)","volume":"1","author":"Tahara","year":"2003","journal-title":"Kampo-no-Rinsho"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1521\/pedi.16.2.113.22547","article-title":"Practice guideline for the treatment of borderline personality disorder: a bridge too far","volume":"16","author":"Typer","year":"2002","journal-title":"J Pers Disord"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4088\/JCP.v66n1013","article-title":"Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target","volume":"66","author":"Villeneuve","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10401239409148834","article-title":"Divalproex sodium in the treatment of aggressive behaviour","volume":"6","author":"Wilcox","year":"1994","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.07.026_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1521\/pedi.1989.3.1.10","article-title":"The Revised Diagnostic Interview for Borderlines: discriminating BPD from other axis II disorders","volume":"3","author":"Zanarini","year":"1989","journal-title":"J Pers Disord"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607002680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607002680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T07:58:24Z","timestamp":1546675104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607002680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0278584607002680"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.07.026","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}